- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00251810
Can CSM Monitor Depth of Anaesthesia Just as Good as BIS?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is a considerable variation in the need of anaesthetics for the individual patient. For measuring the hypnotic component (i.e. sleep) during anaesthesia, no reliable monitoring system was available before Bispectral Index, BIS (Aspect Medical) was commercially launched about ten years ago. BIS is based on complex mathematical and statistical processing of the electroencephalogram, EEG.
A widespread use of BIS has been limited in part by high costs. Last year a considerably cheaper EEG monitor, Cerebral State Monitor, CSM (Danmeter), was launched into the marked. The validation of CSM is so far limited to very few cases comparing BIS and CSM offline. No large scaled clinical study has been performed to test whether CSM also reflects depth of hypnosis in a reliable way.
We set up a study on 60 relatively healthy patients, undergoing various kind of surgery in general anaesthesia. The study is approved by the Regional Committee of Ethics in Medicine, Health Region East, and all patients give written informed consent. Both monitors (BIS and CSM) are applied to the patients, but only information from BIS is available for the anaesthetist throughout surgery. Information from the two monitors and from the routine monitoring equipment as well as from the actual delivery of anaesthetics is sampled online into a designed data program (Rugloop, Demed, Belgium).
The output from BIS and CSM will afterwards be analyzed together with statistical experts, to see if CSM can predict the time for falling asleep and time for awakening just as good as BIS. The curves for the two monitors will also be compared, qualitatively and quantitatively, to see if they perform equally well.
Inclusion criterias:
- Written informed consent
- ASA 1-3
- Age 18 - 75
- Surgery in all parts of the body except from the face/head in general anaesthesia; surgery expected to last for 30 - 120 minutes
Exclusion criterias:
- Extreme over- or underweight
- Epilepsy or other conditions or medications that would probably influence on the EEG
- Alcohol- or drug abuse
- Contraindication for the actual anaesthetics, being propofol and remifentanil
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0407
- Department of Anaesthesia, Ullevaal University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy patients undergoing surgery in general anaesthesia
Exclusion Criteria:
- No ability to give written informed consent, drug abuse, patients on medication suspected or known to influence the EEG, surgery involving head or face
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
general anaesthesia
|
All patients monitored with BIS and CSM, results hidden for the anesthesiologist.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Johan Raeder, professor, University of Oslo
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CSMtrial
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.